Trading the massive valuation gap ahead of crucial earnings reports for the unh stock price
UNH trades at $374 with a forward P/E of 17.76 and a consensus target of $481.72. That 29% gap between the current unh stock price and the analyst target is wide for a $336 billion healthcare company with $450 billion in annual revenue.
The gap exists because the Optum Health margin recovery is still unproven over multiple quarters. Q2 showed 160 basis points of improvement, but one quarter does not confirm a trend. Q3 earnings in mid-October will either narrow the gap (margin recovery continues) or widen it (margin stalls or reverses).
I trade this using Bitunix TradFi equity perpetuals. Long ahead of earnings if estimate revisions are trending up, with 2x leverage and a stop at 3%. The unh stock price typically moves 3% to 5% on earnings day. Perpetuals carry leverage and liquidation risk. Your results may differ.
$UNH #UNHStockPrice #Healthcare #Earnings
UNH trades at $374 with a forward P/E of 17.76 and a consensus target of $481.72. That 29% gap between the current unh stock price and the analyst target is wide for a $336 billion healthcare company with $450 billion in annual revenue.
The gap exists because the Optum Health margin recovery is still unproven over multiple quarters. Q2 showed 160 basis points of improvement, but one quarter does not confirm a trend. Q3 earnings in mid-October will either narrow the gap (margin recovery continues) or widen it (margin stalls or reverses).
I trade this using Bitunix TradFi equity perpetuals. Long ahead of earnings if estimate revisions are trending up, with 2x leverage and a stop at 3%. The unh stock price typically moves 3% to 5% on earnings day. Perpetuals carry leverage and liquidation risk. Your results may differ.
$UNH #UNHStockPrice #Healthcare #Earnings